Glaucoma is a vision robbing disease that if left untreated can cause irreversible vision loss – it’s among the leading causes of blindness worldwide. In its most common form, increased pressure within the eye causes damage to the optic nerve. This pressure is often the result of faulty drainage at the front of the eye.
There are several treatments for glaucoma, but early detection is key to maintaining vision. Less invasive means of treatments include regular use of medicated eye drops. If eye drops prove ineffective, your surgeon may suggest alternative procedures, including surgery.
Among the surgeries performed to treat glaucoma is the use of the Xen Gel Stent, a cutting edge medical implant designed for use with minimally invasive glaucoma surgery. The stent creates a small channel in the eye to help drain excess fluid to maintain a healthier eye pressure.
The stent is very small, about the length of an eyelash, and is placed under the conjunctiva to allow a freer flow out of the extra eye fluid. This tiny device is designed to stay in the eye permanently, so no further surgeries are required.
Patients appreciate that surgery with Xen Gel Stent is performed as a standalone procedure, or at the time of cataract surgery. It is also considered safer than traditional glaucoma surgeries, is less invasive, and has less recovery time (usually less than a week), which all contribute to fewer overall complications.
All Tower Clock Eye Center physicians treat glaucoma, but our fellowship trained surgeon Dr. Kurt Schwiesow, MD, has extensive training in the disease. If you’re looking for state-of-the-art glaucoma care, contact us at 920 499-3102 to schedule an appointment.
Watch Tower Clock Eye Center optometrist Dr. Michael Servi, OD, discuss severe dry eye treatments including bandage soft contact lenses, serum tears and scleral lenses. Most dry eye cases are treated with drops or punctal plugs, but severe dry eye cases require specialized care from the physicians at Tower Clock Eye Center. For appointments call... read more
Age-related Macular Degeneration (AMD) Clinical Trials, Stem Cells, and Other Therapies A Free Research Update Saturday September 23rd 2023 • 10:00 am Lawrence University Music-Drama Center, Stansbury Theater Register here Come hear the latest from UW scientists The McPherson Eye Research Institute at UW-Madison is the home of researchers and clinicians working on AMD and other vision... read more